PAD 20/20's founders envisioned a world where Alzheimer’s could be preemptively challenged. Their strategic plan wasn't just a roadmap; it was a promise of proactive resilience: expand research, cultivate intervention strategies, and breed a nuanced understanding of the socio-economic intricacies linked to neurodegenerative diseases.

The campaign's long-term goal to halve the prevalence of disorders such as Alzheimer's within the 2020s was based on a simple yet transformative concept: modestly delaying the onset of AD could precipitate a drastic decline in both disease incidence and associated costs. PAD 20/20 wasn't merely a preventative campaign; it was a paradigm shift towards an age of anticipation rather than reaction—a crusade with the foresight to set a new precedent for how society confronts the inevitability of aging and illness.